Clinical Trial Update: Phase 2 Study of TVB-2640 in KRAS Non-Small Cell Lung Carcinomas [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of TVB-2640 in KRAS-mutant non-small cell lung cancer is listed as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• TVB-2640

Snippet

Sponsor: David E Gerber | Conditions: KRAS Gene Mutation | Phase 2 | Status: ACTIVE_NOT_RECRUITING